Enhanced Genomics has formed a partnership with The ALBORADA Drug Discovery Institute at the University of Cambridge to ...

The Global Bioinformatics Market is expected to grow at a rate of 13-14% by 2029. The rising government initiatives and ...

Enhanced Genomics and The ALBORADA Drug Discovery Institute are now exploring opportunities to expand their partnership to other neurodegenerative diseases.

We are delighted that The ALBORADA Drug Discovery Institute and Enhanced Genomics have joined forces to accelerate the dementia drug discovery process.

Enhanced Genomics and The ALBORADA Drug Discovery Institute are now exploring opportunities to expand their partnership to other neurodegenerative diseases.

Enhanced Genomics and The ALBORADA Drug Discovery Institute are now exploring opportunities to expand their partnership to other neurodegenerative diseases. The company is also open to ...

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

Enhanced Genomics and The ALBORADA Drug Discovery Institute are now exploring opportunities to expand their partnership to other neurodegenerative diseases. The company is also open to partnerships ...

Enhanced Genomics partners with ALBORADA Drug Discovery Institute to identify novel Alzheimer’s drug targets using 3D multi-omics.

A pioneer in AI explains why he’s more enthusiastic than ever about AI for drug discovery.